在琼脂中对亚抑菌浓度的诺氟沙星产生耐药性增加的微生物的快速筛选。
Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
作者信息
Tenney J H, Maack R W, Chippendale G R
出版信息
Antimicrob Agents Chemother. 1983 Jan;23(1):188-9. doi: 10.1128/AAC.23.1.188.
Abstract
Serial passage of Pseudomonas aeruginosa ATCC 27853 or Escherichia coli ATCC 25922 on agar with subinhibitory concentrations of norfloxacin rapidly produced isolates with minimal inhibitory concentrations (MICs) of norfloxacin up to 512-fold higher than that for the original strain. Although MICs of seven unrelated antibiotics were unchanged, increasing MICs occurred in parallel with norfloxacin, cinoxacin, and nalidixic acid regardless of which of these three organic acids was used to select for increased resistance. P. aeruginosa with a norfloxacin MIC of greater than 256 micrograms/ml could be selected; however, E. coli with MICs greater than the clinically achievable level of 16 micrograms/ml could not be produced.
摘要
在含有亚抑菌浓度诺氟沙星的琼脂上对铜绿假单胞菌ATCC 27853或大肠埃希菌ATCC 25922进行连续传代，很快就产生了对诺氟沙星的最低抑菌浓度（MIC）比原始菌株高512倍的分离株。尽管七种不相关抗生素的MIC没有变化，但无论使用这三种有机酸中的哪一种来选择增加耐药性，对诺氟沙星、西诺沙星和萘啶酸的MIC增加都是并行发生的。可以选择诺氟沙星MIC大于256微克/毫升的铜绿假单胞菌；然而，无法产生MIC大于临床可达到水平16微克/毫升的大肠埃希菌。
相似文献
1
Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.在琼脂中对亚抑菌浓度的诺氟沙星产生耐药性增加的微生物的快速筛选。
Antimicrob Agents Chemother. 1983 Jan;23(1):188-9. doi: 10.1128/AAC.23.1.188.
2
In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.诺氟沙星与萘啶酸、西诺沙星和恶喹酸的体外比较。
Arzneimittelforschung. 1983;33(12):1623-7.
3
Antibacterial activity of norfloxacin.诺氟沙星的抗菌活性。
Antimicrob Agents Chemother. 1983 Jan;23(1):15-8. doi: 10.1128/AAC.23.1.15.
4
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.体外筛选耐药菌群体后，西诺沙星、环丙沙星、DJ - 6783、依诺沙星、萘啶酸、诺氟沙星和恶喹酸之间的交叉耐药性。
Antimicrob Agents Chemother. 1984 Jun;25(6):775-7. doi: 10.1128/AAC.25.6.775.
5
In vitro emergence of Escherichia coli and Pseudomonas aeruginosa strains resistant to norfloxacin and nalidixic acid.体外出现对诺氟沙星和萘啶酸耐药的大肠杆菌和铜绿假单胞菌菌株。
Eur J Clin Microbiol. 1983 Dec;2(6):600-1. doi: 10.1007/BF02016577.
6
Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.诺氟沙星与其他十五种抗假单胞菌药物对庆大霉素敏感和耐药铜绿假单胞菌菌株的比较活性。
Antimicrob Agents Chemother. 1983 Oct;24(4):602-4. doi: 10.1128/AAC.24.4.602.
7
In vitro antibacterial activity of norfloxacin (MK-0366).诺氟沙星（MK-0366）的体外抗菌活性
Antimicrob Agents Chemother. 1982 Apr;21(4):604-7. doi: 10.1128/AAC.21.4.604.
8
Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens.诺氟沙星：与其他七种抗菌剂相比，对尿路病原体的体外活性。
Acta Pathol Microbiol Immunol Scand B. 1984 Apr;92(2):101-6. doi: 10.1111/j.1699-0463.1984.tb02802.x.
9
In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.MK-0366对包括耐庆大霉素铜绿假单胞菌在内的临床尿路病原体的体外活性。
Antimicrob Agents Chemother. 1982 Apr;21(4):670-2. doi: 10.1128/AAC.21.4.670.
10
In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.与西诺沙星、萘啶酸和吡哌酸相比，诺氟沙星在合成培养基和人尿中的体外活性。
Methods Find Exp Clin Pharmacol. 1983 Dec;5(10):731-4.
引用本文的文献
1
Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia.在治疗海藻希瓦氏菌菌血症期间，因对碳青霉烯类药物产生耐药性而导致治疗失败。
J Clin Microbiol. 2006 Mar;44(3):1172-4. doi: 10.1128/JCM.44.3.1172-1174.2006.
2
Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin.幽门螺杆菌基因rdxA和pbp1的突变会导致对甲硝唑和阿莫西林产生耐药性。
Antimicrob Agents Chemother. 2001 Mar;45(3):962-5. doi: 10.1128/AAC.45.3.962-965.2001.
3
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.在缺乏AcrAB外排泵的情况下，拓扑异构酶突变在介导大肠杆菌临床上显著的氟喹诺酮耐药性方面无效。
Antimicrob Agents Chemother. 2000 Jan;44(1):10-3. doi: 10.1128/AAC.44.1.10-13.2000.
4
Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.体外筛选的大肠杆菌氟喹诺酮耐药突变体的特性分析
Antimicrob Agents Chemother. 1994 Jun;38(6):1284-91. doi: 10.1128/AAC.38.6.1284.
5
In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.新型羧基喹啉抗菌剂环丙沙星的体外活性
Antimicrob Agents Chemother. 1984 Mar;25(3):331-5. doi: 10.1128/AAC.25.3.331.
6
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.体外筛选耐药菌群体后，西诺沙星、环丙沙星、DJ - 6783、依诺沙星、萘啶酸、诺氟沙星和恶喹酸之间的交叉耐药性。
Antimicrob Agents Chemother. 1984 Jun;25(6):775-7. doi: 10.1128/AAC.25.6.775.
7
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.环丙沙星，一种对需氧菌和厌氧菌均有活性的喹诺酮羧酸化合物。
Antimicrob Agents Chemother. 1984 Mar;25(3):319-26. doi: 10.1128/AAC.25.3.319.
8
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.喹诺酮羧酸依诺沙星的体外活性与诺氟沙星、新型β-内酰胺类、氨基糖苷类及甲氧苄啶的体外活性比较。
Antimicrob Agents Chemother. 1983 Nov;24(5):754-63. doi: 10.1128/AAC.24.5.754.
9
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.喹诺酮类、β-内酰胺类和氨基糖苷类药物对多重抗生素耐药性的选择，特别提及不相关药物类别之间的交叉耐药性。
Antimicrob Agents Chemother. 1984 Dec;26(6):797-801. doi: 10.1128/AAC.26.6.797.
10
The place of quinolones in antibacterial therapy in hospitals.喹诺酮类药物在医院抗菌治疗中的地位。
Pharm Weekbl Sci. 1986 Feb 21;8(1):72-8. doi: 10.1007/BF01975485.
本文引用的文献
1
In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.喹诺酮羧酸类药物诺氟沙星的体外活性与β-内酰胺类、氨基糖苷类及甲氧苄啶的比较。
Antimicrob Agents Chemother. 1982 Jul;22(1):23-7. doi: 10.1128/AAC.22.1.23.
2
A critical evaluation of nalidixic acid in urinary-tract infections.对萘啶酸治疗尿路感染的批判性评价。
N Engl J Med. 1966 Nov 17;275(20):1081-9. doi: 10.1056/NEJM196611172752001.
3
Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.西诺沙星：一种新型合成有机酸的体外抗菌研究
Antimicrob Agents Chemother. 1975 Feb;7(2):159-63. doi: 10.1128/AAC.7.2.159.
4
The responses of Escherichia coli to nalidixic acid.大肠杆菌对萘啶酸的反应。
Chemotherapy. 1978;24(4):249-58. doi: 10.1159/000237789.
5
Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.萘啶酸抗性：参与DNA回旋酶活性的第二个遗传特征。
Proc Natl Acad Sci U S A. 1977 Nov;74(11):4772-6. doi: 10.1073/pnas.74.11.4772.
Zotero 插件